Big Pharma Fights ‘Tooth and Nail’ Against California Drug VoteBy
Proposition 61 is state’s most expensive ballot fight of 2016
Polls find voters supporting price limits for state agencies
Drugmakers are becoming increasingly vocal in fighting a California ballot proposition on drug prices, concerned that the more $100 million in funding raised by lobbies opposing the initiative won’t be enough to stop it.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.